Non-contiguous finished genome sequence and description of Brevibacterium senegalense sp. nov. by Sahare Kokcha et al.
Standards in Genomic Sciences (2012) 7:233-245 DOI:10.4056/sigs.3256677 
 
The Genomic Standards Consortium
 
Non-contiguous finished genome sequence and  
description of Brevibacterium senegalense sp. nov. 
Sahare Kokcha1*, Dhamodharan Ramasamy 1*, Jean-Christophe Lagier1, Catherine Robert1, 
Didier Raoult1 and Pierre-Edouard Fournier1¶ 
1Aix-Marseille Université, Faculté de médecine, 
Correspondence: Pierre-Edouard Fournier (pierre-edouard.fournier@univmed.fr) 
Keywords: Brevibacterium senegalense, genome 
Brevibacterium senegalense strain JC43T sp. nov. is the type strain of Brevibacterium senegalense 
sp. nov., a new species within the Brevibacterium genus. This strain, whose genome is described 
here, was isolated from the fecal flora of a healthy Senegalese patient. B. senegalense is an aero-
bic rod-shaped Gram-positive bacterium. Here we describe the features of this organism, together 
with the complete genome sequence and annotation. The 3,425,960 bp long genome (1 chromo-
some but no plasmid) contains 3,064 protein-coding and 49 RNA genes. 
Introduction 
Brevibacterium senegalense strain JC43T (= CSUR P155 = DSM 25783) is the type strain of B. 
senegalense. sp. nov. This bacterium is a non-motile, rod-shaped, Gram-positive, catalase-positive bacterium that was isolated from the stool of a healthy Senegalese patient as part of a study aiming at cultivating individually all bacte-rial species within human feces. Bacterial taxonomy has undergone many changes over recent years. The DNA-DNA hybridization and G+C content criteria, once considered as gold standards [1], were gradually replaced by gene sequencing. In particular, 16S rRNA sequencing has deeply changed the way bacteria and archaea are classified [2]. More recently, the development of high throughput genome sequencing methods and mass spectrometric analyses of bacteria have provided a wealth of genetic and proteomic in-formation [3]. We recently used a polyphasic ap-proach [4] that includes genomic data, MALDI-TOF spectrum and major phenotypic characteris-tics to describe new bacterial species  [5-11]. The genus Brevibacterium (Breed 1953) [12] was created in 1953 to gather short non-spore-forming and non-branching rods. To date, this ge-nus is comprised of Gram-positive, irregular, rod-shaped, non-acid-fast bacteria, and contains 31 recognized species with validly published names [13]. Brevibacterium is the type genus of the fami-ly Brevibacteriaceae (Breed 1953) [14]. Members of the genus Brevibacterium are isolated from  
human samples, dairy products, poultry and envi-ronmental specimens. In humans, they are found on skin surfaces [15], but have also been demon-strated to cause rare cases of bacteremia, endo-carditis, pericarditis, brain abscess and peritonitis. These infections have been observed mainly in immunocompromised patients [10-19], with the exception of two cases of bacteremia in immunocompetent patients with central venous catheters [9,19]. To date, only four Brevibacterium species have been detected in human infection, including B. epidermidis (Collins et al. 1983) [15,16,17], B. casei (Collins et al. 1983) [18,20], B. 
iodinum (Collins et al. 1981) and B. otitidis (Pascual et al. 1996). Here we present a summary classification and a set of features for B. senegalense sp. nov. strain JC43T together with the description of the com-plete genomic sequencing and annotation. These characteristics support the circumscription of the 
B. senegalense species. 
Organism information A stool sample was collected from a healthy 16-year-old male Senegalese volunteer patient living in Dielmo (rural village in the Guinean-Sudanian zone in Senegal), who was included in a research protocol. Written assent was obtained from this individual. No written consent was needed from his guardians for this study because he was older than 15 years old (in accordance with the previous pro-ject approved by the Ministry of Health of Senegal 
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and the assembled village population, and as pub-lished elsewhere [20]. Both this study and the as-sent procedure were approved by the National Eth-ics Committee of Senegal (CNERS) and the Ethics Committee of the Institut Fédératif de Recherche IFR48, Faculty of Medicine, Marseille, France (agreement numbers 09-022 and 11-017)). Several other new bacterial species were isolated from this specimen using various culture conditions, includ-ing the recently described Alistipes timonensis, A. 
senegalensis, Anaerococcus senegalensis, Bacillus 
timonensis, Clostridium senegalense, Paenibacillus 
senegalensis, and Peptoniphilus timonensis [5-11]. The fecal specimen was preserved at -80°C after collection and sent to Marseille. Strain JC43T (Table 1) was isolated in December 2010 after inoculation on Brucella agar (BD diagnostic, Heilderberg, Ger-many), in aerobic atmosphere at 37°C. 
The strain exhibited 97.1 and 96.7% nucleotide sequence similarities with B. salitolerans (Guan et 
al. 2010) and B. album (Tang et al. 2008), respec-tively, the phylogenetically closest validated 
Brevibacterium species (Figure 1). These values were lower than the 98.7% 16S rRNA gene se-quence threshold recommended by Stackebrandt and Ebers to delineate a new species without car-rying out DNA-DNA hybridization [2]. In compari-son to 16S sequences in the GenBank database [30], strain JC43T also exhibited nucleotide se-quence similarities greater than 98.7% with un-cultured bacterial clones detected in water-miscible metalworking fluids [31] and on clean room surfaces [32]. These bacteria most likely be-long to the same species as strains JC43 (Figure 1). 
Table 1. Classification and general features of Brevibacterium senegalense strain JC43T according to the 
MIGS recommendations [21] 
MIGS ID Property Term Evidence codea 
  Domain Bacteria TAS [22] 
  Phylum Actinobacteria TAS [23] 
  Class Actinobacteria TAS [24] 
 Current classification Order Actinomycetales TAS [24-27] 
  Family Brevibacteriaceae TAS [24,25,27,28] 
  Genus Brevibacterium TAS [14,25] 
  Species Brevibacterium senegalensis IDA 
  Type strain JC43T IDA 
 Gram stain positive IDA 
 Cell shape rod IDA 
 Motility nonmotile IDA 
 Sporulation nonsporulating IDA 
 Temperature range Mesophile IDA 
 Optimum temperature 30 - 37°C IDA 
MIGS-6.3 Salinity unknown IDA 
MIGS-22 Oxygen requirement aerobic IDA 
 Carbon source glucose  
 Energy source chemoorganotrophic  
MIGS-6 Habitat human gut IDA 
MIGS-15 Biotic relationship free living IDA 
 Pathogenicity Unknown  
 Biosafety level 2  
MIGS-14 Isolation human feces  
MIGS-4 Geographic location Senegal IDA 
MIGS-5 Sample collection time September 2010 IDA 
MIGS-4.1 Latitude – 13.7167 IDA 
 Longitude -16.4167  
MIGS-4.3 Depth surface IDA 
MIGS-4.4 Altitude 51 m above sea level IDA 
aEvidence codes - IDA: Inferred from Direct Assay (first time in publication); TAS: Traceable Author 
Statement (a direct report exists in the literature); NAS: Non-traceable Author Statement (not directly ob-
served for the living, isolated sample, but based on a generally accepted property of the species, or an-
ecdotal evidence). These evidence codes are from the Gene Ontology project [29]. 
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Figure 1. Phylogenetic tree highlighting the position of Brevibacterium senegalense strain JC43T relative to other 
type strains within the genus Brevibacterium. GenBank accession numbers are indicated in parentheses. Sequences 
were aligned using CLUSTALW, and phylogenetic inferences obtained using the maximum-likelihood method 
within the MEGA software. Numbers at the nodes are percentages of bootstrap values obtained by repeating 500 
times the analysis to generate a majority consensus tree. The dashed-line square shows sequences that exhibit de-
grees of similarity > 99% with B. senegalense (same species). Asterisks indicate the species for which genome se-
quences are currently available. 
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Different growth temperatures (25, 30, 37, 45°C) were tested; no growth occurred at 45°C, weak growth occurred at 25°C, and optimal growth was observed between 30 to 37°C. Colonies were translucent and smooth, with a di-ameter of 1 mm on blood-enriched Columbia agar and Brain Heart Infusion (BHI) agar. Growth of the strain was tested under anaerobic and microaerophilic conditions using GENbag anaer and GENbag microaer systems, respectively (BioMérieux), and in the presence of air, of 5% CO2 and in aerobic conditions. Optimal growth was obtained aerobically and with 5% CO2. Weak growth was observed under microaerophilic con-ditions. No growth was observed in an anaerobic atmosphere. Gram staining showed Gram-positive rods. A mo-tility test was negative. Cells grown on agar are Gram-positive (Figure 2) and are mostly grouped in small clumps (Figure 3). Their length and width range from 0.83 to 3.86 µm (mean, 2.55 µm) and 0.57 to 0.78 µm (mean, 0.68 µm), respectively. Strain JC43T exhibited catalase activity but not oxidase activity. Using the API CORYNE sys-tem(BioMérieux),  positive reactions were ob-served for nitrate reduction, pyrrolidonyl 
arylamidase, alkaline phosphatase, α-glucosidase. A weak reaction was observed for gelatin hydroly-sis. Negative reactions were observed for urease, 
pyrazinamidase, β-glucuronidase, β-galactosidase, 
α-glucosidase, N-acetyl-β-glucosaminidase, β-glucosidase (aesculin hydrolysis), and acid pro-duction from D-ribose, D-glucose, D-xylose, D-mannitol, maltose, D-lactose, sucrose and glyco-gen. Using API ZYM (BioMérieux), positive reac-tions were observed for esterase (C4), esterase lipase (C8), leucine arylamidase and acid and alka-line phosphatase. Negative reactions were ob-served for valine arylamidase, cystine 
arylamidase, trypsin, α-chymotrypsin, naphtol-AS-BI-phosphohydrolase, lipase, α-galactosidase, β-
galactosidase, β-glucuronidase, α-glucosidase, β-glucosidase, N-acetyl-β-glucosaminidase, α-
mannosidase and α-fucosidase. B. senegalense is susceptible to penicillin G, amoxicillin, imipenem, ciprofloxacin, rifampin, gentamicin, doxycycline and vancomycin but resistant to trime-thoprim/sulfamethoxazole and metronidazole. By comparison to B. salitolerans [33] and B. album [34], B. senegalense strain JC43T differed in growth temperature, gelatin hydrolysis, pyrazinamidase, acid production from D-ribose, and nitrate reduc-tion. In addition, B. senegalense also differed from 
the former species in β-glucosidase (aesculin hy-drolysis) activity [33], and from the latter species in motility, valine arylamidase, cystine 
arylamidase, trypsin, α-chymotrypsin and naphtol-AS-BI-phosphohydrolase activities [34]. 
 
Figure 2. Gram staining of B. senegalense strain JC43T 
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Figure 3. Transmission electron microscopy of B. senegalense strain JC43T, using a 
Morgani 268D (Philips) at an operating voltage of 60kV. The scale bar represents 
200 nm. 
 Matrix-assisted laser-desorption/ionization time-of-flight (MALDI-TOF) MS protein analysis was carried out as previously described [5,35] using a Microflex spectrometer (Bruker Daltonics, Ger-many). Twelve distinct deposits were done for strain JC43T from four isolated colonies. The 12 JC43T spectra were imported into the MALDI BioTyper software (version 2.0, Bruker) and ana-lyzed by standard pattern matching (with default parameter settings) against the main spectra of 3,769 bacteria, which were used as reference data, in the BioTyper database. The database contained 41 spectra from 18 validly published 
Brevibacterium species, including B. avium,  B. 
celere, B. casei, B. aurantiacum, B. epidermidis, B. 
iodinum, B. linens, B. luteolum, B. marinum, B. 
massiliense, B. mcbrellneri, B. otitidis, B. 
paucivorans, B. picturae, B. pityocampae, B. 
ravenspurgense, B. sanguinis and B. stationis. No 
significant score was obtained for strain JC43, thus suggesting that our isolate was not a member of a known Brevibacterium species within the Bruker database. We incremented our database with the spectrum from strain JC43 (Figure 4). 
Genome sequencing and annotation 
Genome project history The organism was selected for sequencing on the basis of its phylogenetic position and 16S rRNA similarity to other members of the Brevibacterium genus, and is part of a study aiming at isolating all bacterial species within human feces. It was the third genome of a Brevibacterium species. The ge-nome EMBL accession number is CAHK00000000 and consists of 80 contigs. Table 2 shows the pro-ject information and its association with MIGS version 2.0 compliance. 
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Figure 4. Reference mass spectrum from B. senegalense strain JC43T. Spectra from 4 individual colonies were 
compared and a reference spectrum was generated. 
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Table 2. Project information 
MIGS ID Property Term 
MIGS-31 Finishing quality High quality draft 
MIGS-28 Libraries used One shotgun, one paired-end 3-kb 
MIGS-29 Sequencing platforms 454 GS FLX Titanium 
MIGS-31.2 Fold coverage 20 × 
MIGS-30 Assemblers Newbler version 2.5.3 
MIGS-32 Gene calling method Prodigal 
 EMBL ID CAHK00000000 
 EMBL date of Release February 2, 2012 
 Project relevance Study of the human gut microbiot 
Growth conditions and DNA isolation 
B. senegalense sp. nov. strain JC43T (CSUR = P155, DSM = 25783) was grown aerobically on 5% sheep blood-enriched Columbia agar at 37°C. Seven petri dishes were spread and resuspended in 3x100µl of G2 buffer (EZ1 DNA Tissue kit, Qiagen). A first me-chanical lysis was performed by glass powder on the Fastprep-24 device (Sample Preparation system; MP Biomedicals, USA) using 2x20 seconds cycles. DNA was then treated with 2.5µg/µL lysozyme (30 minutes at 37°C) and extracted through the BioRobot EZ 1 Advanced XL (Qiagen). The DNA was then con-centrated and purified on a Qiamp kit (Qiagen). The yield and the concentration was measured by the Quant-it Picogreen kit (Invitrogen) on the Genios_Tecan fluorometer at 68,1 ng/µl. 
Genome sequencing and assembly A shotgun library and a 3kb paired end library were pyrosequenced on the 454 Roche Titanium sequenc-ing platform. This project was loaded on one 1/4 region region of PTP Picotiterplate (Roche, Meylan, France) for the shotgun library and 4 ×  1/4 region for the 3-kb paired-end library. The shotgun library was constructed with 500 ng of DNA with the GS Rapid library Prep kit as described by the manufac-turer (Roche). For the paired-end library, 5µg of DNA was mechanically fragmented on a Hydroshear device (Digilab, Holliston, MA, USA) with an enrich-ment size at 3-4kb. DNA fragmentation was visual-ized using an Agilent 2100 BioAnalyzer on a DNA labchip 7500 with an optimal size of 3.692 kb. The library was constructed according to the 454 Titani-um paired-end protocol (Roche). Circularization and nebulization were performed and generated a pat-tern with an optimum of 510 bp. After PCR amplifi-cation through 15 cycles followed by double size selection, the single stranded paired-end library was 
then quantified using a Quant-it Ribogreen kit (Invi-trogen) on a Genios Tecan fluorometer at 245 pg/µL. The library concentration equivalence was calculat-ed at 8.80E+08 molecules/µL. The libraries were stocked at -20°C until further use. The shotgun library was clonally amplified with 3 cpb in 3 emPCR reactions and the 3-kb paired-end library was amplified with 1 cpb in 10 emPCR reac-tions and 0.25 cpb in 4 emPCR with the GS Titani-um SV emPCR Kit (Lib-L) v2 (Roche). The yield of the shotgun emPCR reactions was higher than ex-pected at 24%, but the yields of the two types of paired-end emPCR were 16.7% and 11.01%, re-spectively, in the range of 5 to 20% from the Roche procedure. The libraries were loaded on the GS Titanium PicoTiterPlate PTP Kit 70×75 and sequenced with the GS FLX Titanium Sequencing Kit XLR70 (Roche). The runs were performed overnight and then analyzed on the cluster through the gsRunBrowser and Newbler Assembler (Roche). A total of 752,121 passed filter wells were obtained and generated 203.1 Mb of sequence with an aver-age length of 265 bp. The passed filter sequences were assembled using Newbler with 90% identity and 40 bp as overlap. The final assembly identified 80 contigs (>500 bp) arranged into 16 scaffolds and generated a genome size of 3.42 Mb. 
Genome annotation Open Reading Frames (ORFs) were predicted using Prodigal [36] with default parameters but the pre-dicted ORFs were excluded if they were spanning a sequencing GAP region. The predicted bacterial protein sequences were searched against the GenBank database and the Clusters of Orthologous Groups (COG) database using BLASTP. The 
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tRNAScanSE tool [37] was used to find tRNA genes, whereas ribosomal RNAs were found using RNAmmer [38]. Transmembrane domains and sig-nal peptides were predicted using TMHMM [39] and SignalP [40], respectively. ORFans were identi-fied if their BLASTp E-value was lower than 1e-03 for alignment length greater than 80 amino acids. If alignment lengths were smaller than 80 amino ac-ids, we used an E-value of 1e-05. To estimate the mean level of nucleotide sequence similarity at the genome level between B. senegalense, B. linens (GenBank accession number AAGP00000000) and 
B. mcbrellneri (ADNU00000000) we compared the ORFs only using BLASTN at a query coverage of ≥ 70% and a minimum nucleotide length of 100 bp. 
Genome properties The genome is 3,425,960 bp long (1 chromosome, but no plasmid) with a 70.00% G+C content (Table 3 and Figure 5). Of the 3,114 predicted genes, 3,065 were protein-coding genes and 49 were RNAs, including 3 rRNA operons (5S, 16S and 23S rRNA) and 40 tRNAs. A total of 2,077 genes (66.7%) were assigned a putative function. The distribution of genes into COGs functional catego-ries is presented in Table 4 and Figure 5. The properties and the statistics of the genome are summarized in Tables 3 and 4. 
 
 
Figure 5. Graphical circular map of the Brevibacterium senegalense genome. From outside to the cen-
ter: genes on the forward strand (colored by COG categories), genes on the reverse strand (colored by 
COG categories), RNA genes (tRNAs, green; rRNAs, red), G+C content, GC skew. 
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Table 3. Nucleotide content and gene count levels of the genome 
Attribute Value % of totala 
Genome size (bp) 3,425,960 100 
DNA coding region (bp) 3,115,812 90.94 
DNA G+C content (bp) 2,398,172 70.00 
Total genes 3,114 100 
RNA genes 49 1.57 
Protein-coding genes 3,064 98.39 
Genes with function prediction 2,378 76.36 
Genes assigned to COGs 2,077 66.69 
Genes with peptide signals 181 5.8 
Genes with transmembrane helices 317 10.17 
aThe total is based on either the size of the genome in base pairs 
or the total number of protein coding genes in the annotated ge-
nome 
Table 4. Number of genes associated with the 25 general COG functional categories 
Code Value % of totala Description 
J 149 4.86 Translation 
A 1 0.032 RNA processing and modification 
K 163 5.31 Transcription 
L 176 5.74 Replication, recombination and repair 
B 0 0 Chromatin structure and dynamics 
D 24 0.78 Cell cycle control, mitosis and meiosis 
Y 0 0 Nuclear structure 
V 47 1.53 Defense mechanisms 
T 52 1.69 Signal transduction mechanisms 
M 105 3.42 Cell wall/membrane biogenesis 
N 0 0 Cell motility 
Z 0 0 Cytoskeleton 
W 0 0 Extracellular structures 
U 26 0.84 Intracellular trafficking and secretion 
O 76 2.47 Posttranslational modification, protein turnover, chaperones 
C 139 4.53 Energy production and conversion 
G 88 2.87 Carbohydrate transport and metabolism 
E 189 6.16 Amino acid transport and metabolism 
F 63 2.05 Nucleotide transport and metabolism 
H 72 2.34 Coenzyme transport and metabolism 
I 123 4.01 Lipid transport and metabolism 
P 127 4.14 Inorganic ion transport and metabolism 
Q 25 0.81 Secondary metabolites biosynthesis, transport and catabolism 
R 250 8.15 General function prediction only 
S 182 5.93 Function unknown 
- 301 9.82 Not in COGs 
a The total is based on the total number of protein coding genes in the annotated genome 
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Genomic comparison with B. linens  
and B. mcbrellneri Currently, two draft genomes from Brevibacterium species are available. By comparison with B. linens strain BL2 (GenBank accession number AAGP00000000) and B. mcbrellneri strain ATCC 49030 (ADNU00000000) B. senegalense strain JC43T has a smaller genome than the former (3.42 Mb vs 4.37Mb) but larger than the latter (2.56Mb). 
B. senegalense also has a higher G+C content than the other two genomes (70.00% vs 62.8% and 58.00%, respectively); it has a smaller number of predicted genes (3,114) than B. linens (4,054) but greater than B. mcbrellneri (2,437). Finally, at the 
genome level, B. senegalense exhibited percentages of nucleotide sequence similarity of 86.28% (range 70.01-100%) and 70.19% (range 86.09-100%) with B. linens and B. mcbrellneri, respectively. 
Conclusion On the basis of phenotypic (Table 5), phylogenetic and genomic analyses, we formally propose the creation of Brevibacterium senegalense sp. nov. that contains the strain JC43T. This bacterium originated from Senegal. 
Table 5. Phenotypic differences observed between B. senegalense strain JC43T, B. salitolerans strain YIM90718 and 
B. album strain TRM415. 
 B. senegalense JC43T B. album TRM415 B. salitolerans YIM90718 
Motility - + - 
Catalase + + + 
Oxydase - - - 
Spore-forming - - - 
T° of growth 25-37°C 28-45°C 15-50°C 
Gelatin hydrolysis W + + 
Alkaline phosphatase + + + 
Esterase lipase C8 + + NA 
Pyrazinamidase - + + 
Nitrate reduction + - - 
β -glucuronidase - - - 
β - galactosidase - - - 
N-acetyl- β -glucosamidase - - - 
β -glucosidase (aesculin hydrolysis) - - + 
α-glucosidase - - - 
urease - - - 
Acid production for    
D-ribose - + + 
D-glucose - - - 
Description of Brevibacterium senegalense sp. nov. 
Brevibacterium senegalense (se.ne.gal.e’n.se L. gen. neutr. n. senegalense, pertaining to, or originating from Senegal, the country from which the speci-men that enabled isolation of B. senegalense was isolated.) Colonies are translucent, smooth and have a di-ameter of 1 mm on blood-enriched Columbia agar and Brain Heart Infusion (BHI) agar. Cells are rod-shaped and occur mostly in small clumps. Their length and width range from 0.83 to 3.86 µm (mean, 2.55 µm) and 0.57 to 0.78 µm (mean, 0.68 µm), respectively. Optimal growth is achieved aerobically with or without CO2. Weak growth is observed under microaerophilic conditions. No 
growth is observed under anaerobic conditions. Growth occurs between 30-37°C. Cells stain Gram-positive, are non-endospore-forming, and non-motile. Catalase, nitrate reduction, pyrrolidonyl arylamidase, alkaline phosphatase, α-glucosidase, gelatin hydrolysis, esterase (C4), esterase lipase (C8), leucine arylamidase and acid and alkaline phosphatase activities are present. Urease, 
pyrazinamidase, β-glucuronidase, β-galactosidase, 
α-glucosidase, N-acetyl-β-glucosaminidase, β-glucosidase (aesculin hydrolysis), acid production from D-ribose, D-glucose, D-xylose, D-mannitol, maltose, D-lactose, sucrose and glycogen, valine 
aylamidase, cystine aylamidase, trypsin, α-
Kokcha et al. 
http://standardsingenomics.org 243 
chymotrypsin, naphtol-AS-BI-phosphohydrolase, lipase, α-galactosidase, β-galactosidase, β-
glucuronidase, α-glucosidase, β-glucosidase, N-acetyl-β-glucosaminidase, α-mannosidase and α-fucosidase activities are absent. Oxidase activity is absent. Cells are susceptible to penicillin G, amoxi-cillin, imipenem, ciprofloxacin, rifampin, gentami-cin, doxycycline and vancomycin, but resistant to 
trimethoprim/sulfamethoxazole and metronida-zole. The G+C content of the genome is 70.00%. The 16S rRNA and genome sequences are deposited in EMBL under accession numbers JF824806 and CAHK00000000, respectively. The type strain JC43T (= CSUR P 155 = DSM 25783) was isolated from the fecal flora of a healthy patient in Senegal. 
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